L-menthol
Sponsors
Sakao Seiichiro, Teikyo University Mizonokuchi Hospital Department of Gastroenterology, Aalborg University, Taipei Veterans General Hospital, Taiwan, Region Skane
Conditions
AsthmaBile duct stoneChronic Obstructive Pulmonary Disease (COPD)Chronic obstructive pulmonary disease, Idiopathic interstitial pneumonias
chronic respiratory failureDermatology/Skin - OtherInterstitial Lung Disease (ILD)ItchNeuropathic Pain
Phase 2
A prospective pilot study of the usefulness of l-menthol as antispasmodic drug during ERCP.
Active, not recruitingJPRN-UMIN000029125
Start: 2016-11-01Target: 100Updated: 2026-06-29
Effects of olfactory stimulation by L-menthol on dyspnea on exertion in chronic lung disease: A pilot study
Active, not recruitingJPRN-jRCTs031200400
Start: 2021-04-14Target: 34Updated: 2026-06-29
Efficacy of L-menthol on Breathlessness in Chronic Obstructive Pulmonary Disease
CompletedNCT05888597
Start: 2023-05-24End: 2025-04-30Updated: 2025-12-09
Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease
RecruitingNCT07398287
Start: 2026-04-13End: 2027-05-01Target: 20Updated: 2026-04-24
Efficacy of L-menthol on Breathlessness in Asthma
RecruitingNCT07500974
Start: 2026-05-07End: 2027-05-01Target: 20Updated: 2026-08-19
Phase 3
Unknown Phase
Desensitization of Nociceptive Afferents by Application of Topical Capsaicin, Trans-cinnamaldehyde and L-menthol
NCT03132142
Start: 2017-04-30End: 2017-08-31Target: 22Updated: 2017-04-27
Characterization of the Toll-like Receptor 7-agonist Imiquimod 3.75% As a New Surrogate Model of Itch
WithdrawnNCT03943407
Start: 2019-11-01End: 2022-06-30Updated: 2024-11-22
Investigation of a New Human Model for Itch
CompletedNCT04711044
Start: 2021-02-01End: 2021-07-05Updated: 2021-07-09